Strongly compromised inflammatory response to brain injury in interleukin-6-deficient mice

GLIA

Volumn 25, Issue 4, 1999, Pages 343-357

  Penkowa, Milena ^a   Moos, Torben ^a   Carrasco, Javier ^b   Hadberg, Hanne ^a   Molinero, Amalia ^b   Bluethmann, Horst ^c   Hidalgo, Juan ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Brain injury; Brain macrophages; Gliosis; GM CSF; IL 6 deficiency; Metallothionein I+II; Metallothionein III; Neurons

Indexed keywords

BLOOD BRAIN BARRIER; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IN SITU HYBRIDIZATION; INFLAMMATION; MACROPHAGE; METALLOTHIONEIN I; METALLOTHIONEIN II; METALLOTHIONEIN III; MONOCYTE; NERVE CELL; PATHOGENESIS;

ANIMALS; ASTROCYTES; BLOOD-BRAIN BARRIER; BRAIN INJURIES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; GROWTH INHIBITORS; IN SITU HYBRIDIZATION; INTERLEUKIN-6; KI-67 ANTIGEN; MACROPHAGES; METALLOTHIONEIN; MICE; MICE, INBRED C57BL; MICROGLIA; NERVE TISSUE PROTEINS; NEURONS;

EID: 0033557201     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1136(19990215)25:4<343::AID-GLIA4>3.0.CO;2-V     Document Type: Article

References (70)

1. Amat JA, Ishiguro H, Nakamura K, Norton WT. 1996. Phenotypic diversity and kinetics of proliferating microglia and astrocytes following cortical stab wounds. Glia 16:368-382.
2. Andersson PB, Perry VH, Gordon S. 1992. The acute inflammatory response to lipopolysaccharide in CNS parenchyma differs from that in other body tissues. Neuroscience 48:169-186.
3. Aschner M. 1996. The functional significance of brain metallothioneins. FASEB J 10:1129-1136.
4. Balasingam V, Tejada-Berges T, Wright E, Bouckova R, Yong VW. 1994. Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines. J Neurosci 14:846-856.
5. Belloso E, Hernández J, Giralt M, Kille P, Hidalgo J. 1996. Effect of stress on mouse and rat brain metallothionein I and III mRNA levels. Neuroendocrinology 64:430-439.
6. Calvo CF, Yoshimura T, Gelman M, Mallat M. 1996. Production of monocyte chemotactic protein-1 by rat brain macrophages. Eur J Neurosci 8:1725-1734.
7. Campbell IL, Abraham CR, Masliah E, Kemper P, Inglis JD, Oldstone MBA, Mucke L. 1993. Neurological diseases induced in transgenic mice by cerebral overexpression of interleukin-6. Proc Natl Acad Sci USA 90:10061-10065.
8. Carrasco J, Hernández J, González B, Campbell IL, Hidalgo J. 1998. Localization of metallothionein-I and -III expression in the CNS of transgenic mice with astrocyte-targeted expression of interleukin 6. Exp Neurol 153:184-194.
9. Chai Z, Gatti S, Toniatti C, Poli V, Bartfai T. 1996. Interleukin (IL.-6) gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1β: a study on IL-6-deficient mice. J Exp Med 183:311-316.
10. Chiang CS, Stadler A, Samini A, Campbell I. 1994. Reactive gliosis as a consequence of interleukin-6 expression in the brain: studies in transgenic mice. Dev Neurosci 16:212-221.
11. Dalton T, Pazdernik TL, Wagner J, Samson F, Andrews GK. 1995. Temporalspatial patterns of expression of metallothionein-I and -III and other stress related genes in rat brain after kainic acid induced seizures. Neurochem Int 27:59-71.
12. De SK, McMaster MT, Andrews GK. 1990. Endotoxin induction of murine metallothionein gene expression. J Biol Chem 265:15267-15274.
13. Duguid JR, Bohmont CW, Liu NG, Tourtelotte WW. 1989. Changes in brain gene expression shared by scrapie and Alzheimer disease. Proc Natl Acad Sci USA 86:7260-7264.
14. Erickson JC, Hollopeter G, Thomas SA, Froelick GJ, Palmiter RD. 1997. Disruption of the metallothionein-III gene in mice: Analysis of brain zinc, behavior and neuron vulnerability to metals, aging and seizures. J Neurosci 17:1271-1281.
15. Erickson JC, Sewell AK, Jensen LT, Winge DR, Palmiter RD. 1994. Enhanced neurotrophic activity in Alzheimer's disease cortex is not associated with down-regulation of metallothionein-III (GIF). Brain Res 649:297-304.
16. Eugster H-P, Frei K, Kopf M, Lassmann H, Fontana A. 1998. IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induce autoimmune encephalomyelitis. Eur J Immunol 28:2178-2187.
17. Faller P, Vasák M. 1997. Distinct metal-thiolate clusters in the N-terminal domain of neuronal growth inhibitory factor. Biochemistry 36:13341-13348.
18. Fujita H, Tanaka J, Toku K, Tateishi N, Suzuki Y, Matsuda S, Sakanaka M, Maeda N. 1996. Effects of GM-CSF and ordinary supplements on the ramification of microglia in culture: a morphometrical study. Glia 18:269-281.
19. Gasull T, Giralt M, Hernández J, Martinez P, Bremmer I, Hidalgo J. 1994. Regulation of metallothionein concentrations in rat brain: effect of glucocorticoids, zinc, copper and endotoxin. Am J Physiol 266:E760-E767.
20. Gasull T, Rebollo DV, Romero B, Hidalgo J. 1993. Development of a competitive double antibody radioimmunoassay for rat metallothionein. J Immunoassay 14:209-215.
21. Gebicke-Haerter PJ, Van Calker D, Nörenberg W, Illes P. 1996. Molecular mechanisms of microglial activation. A. Implications for regeneration and neurogenerative diseases. Neurochem Int 29: 1-12.
22. Gehrmann J. 1995. Colony-stimulating factors regulate programmed cell death of rat microglia/brain macrophages in vitro. J Neuroimmunol 63: 55-61.
23. Giulian D, Ingemann JE. 1988. Colony-Stimulating factors as promoters of ameboid microglia. J Neurosci 8:4707-4717.
24. Giulian D, Chen J, Ingeman JE, George JK, Noponen M. 1989. The role of mononuclear phagocytes in wound healing after traumatic injury to adult mammalian brain. J Neurosci 12:4416-4429.
25. Giulian D, Li J, Li X, George J, Rutecki PA. 1994. The impact of microglia-derived cytokines upon gliosis in the CNS. Dev Neurosci 16:128-136.
26. Hama T, Kushima Y, Miyamoto M, Kubota M, Takei N, Hatanaka H. 1991. Interleukin-6 improves the survival of mesencephalic catecholaminergic and septal cholinergic neurons from postnatal, two-week-old rats in cultures. Neuroscience 40:445-452.
27. Hauser SP, Kajkenova O, Lipschitz DA. 1997. The pivotal role of interleukin 6 in formation and function of hematopoietically active murine long-term bone marrow cultures. Stem Cells 15:125-132.
28. Heinrich P, Castell JV, Andus T. 1990. lnterleukin-6 and the acute phase response. J Biochem 265:621-636.
29. Hernández J, Carrasco J, Arbones ML, Hidalgo J. 1997a. IFN-γR+/+ mice show an enhanced liver and brain metallothionein I+II response to endotoxin but not to immobilization stress. J Endotoxin Res 4:363-370.
30. Hernández J, Molinero A, Campbell IL, Hidalgo J. 1997b. Transgenic expression of interleukin 6 in the central nervous system regulates brain metallothionein-I and -III expression in mice. Mol Brain Res 48:125-131.
31. Hidalgo J, Borras M, Garvey JS, Armario A. 1990. Liver, brain and heart metallothionein induction by stress. J Neurochem 55:651-654.
32. Hidalgo J, Belloso E, Hernández J. Gasull T, Molinero A. 1997. Role of glucocorticoids on rat brain metallothionein-I and -III response to stress. Stress 1:231-240.
33. Hidalgo J, Garcia A, Oliva AM, Giralt M, Gasull T, González B, Milnerowicz H, Wood A, Bremner I. 1994. Effect of zinc, copper and glucocorticoids on metallothionein levels of cultured neurons and astrocytes from rat brain. Chemico-Biol Interactions 93:197-219.
34. Hidalgo J, Castellano B, Campbell IL. 1997. Regulations of brain metallothioneins. Curr Topics Neurochem 1:1-26.
35. Hirano T, Taga T, Matsuda T, Hibi M, Suematsu S, Tang B, Murakami M, Kishimoto T. 1990. Interleukin 6 and its receptor in the immune response and hematopoiesis. Int J Cell Cloning 8:155-166.
36. Hopkins SJ, Rothwell NJ. 1995. Cytokines and the nervous system I: expression and recognition. Trends Neurosci 18:83-88.
37. Hozumi I, Inuzuka T, Hiraiwa M, Uchida Y, Anezaki T, Ishiguro H, Kobayashi H, Uda Y, Miyatake T, Tsuji S. 1995. Changes of growth inhibitory factor after stab wounds in rat brain. Brain Res 688:143-148.
38. Hozumi I, Inuzuka T, Ishiguro H, Hiraiwa M, Uchida Y, Tsuji S. 1996. Immunoreactivity of growth inhibitory factor in normal rat brain and after stab wounds: an immunocytochemical study using confocal laser scan microscope. Brain Res 741:197-204.
39. Inuzuka T, Hozumi I, Tamura A, Hiraiwa M, Tsuji S. 1996. Patterns of growth inhibitory factor (GIF) and glial fibrillary acidic protein relative level changes differ following left middle cerebral artery occlusion in rats. Brain Res 709:151-131.
40. Klein MA, Möller JC, Jones LL, Bluethmann H, Kreutzberg GW, Raivich G. 1997. Impaired neuroglial activation in interleukin-6-deficient mice. Glia 19:227-233.
41. Karin M, Imbra RJ, Heguy A, Wong G. 1985. Interleukin 1 regulates human metallothionein gene expression. Mol Cell Biol 5:2866-2869.
42. Kobayashi H, Uchida Y, Ihara Y, Nakajima K, Kohsaka S, Miyatake T, Tsuji S. 1993. Molecular cloning of rat growth inhibitory factor cDNA and the expression in the central nervous system. Mol Brain Res. 19:188-194
43. Koh JY, Choi DW. 1994. Zinc toxicity in cultured cortical neurons: involvement of N-methyl-D-aspartate receptors. Neuroscience 60: 1049-1057.
44. Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, Kishimoto M, Zinkernagel R, Bluethmann H, Koehler G. 1994. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368:339-342.
45. Lemaire I, Yang H, Lafont V, Dornand J, Commes T, Cantin MF. 1996. Differential effects of macrophage- and granulocyte-macrophage colony-stimulating factors on cytokine gene expression during rat alveolar macrophage differentiation into multinucleated giant cells (MGC): role for IL-6 in type 2 MGC formation. J Immunol 157:5118-5125.
46. LeVine SM, Brown DC. 1997. IL-6 and TNFa expression in brains of twitcher, quaking and normal mice. J Neuroimmunol 73:47-56.
47. Malipiero UV, Frei K, Fontana A. 1990. Production of hemopoietic colony-stimulating factors by astrocytes. J Immunol 144:3816-3821.
48. Mandrup-Poulsen T, Nerup J, Reimers JI, Pociot F, Andersen HU, Karlsen A, Bjerre U, Bergholdt R. 1995. Cytokines and the endocrine system. I. The immunoendocrine network. Eur J Endocrinol 133:660-671.
49. Masters BA, Quaife CJ, Erickson JC, Kelly EJ, Froelick GJ, Zambrowicz BP, Brinster RL, Palmiter RD. 1994. Metallothionein III is expressed in neurons that sequester zinc in synaptic vesicles. J Neurosci 14:5844-5857.
50. Mendel I, Katz A, Kozak N, Ben-Nun A, Revel M. 1998. Interleukin-6 functions in autoimmune encephalomyelitis: a study in genetargeted mice. Eur J Immunol 28:1727-1737.
51. Moos T, Høyer PE. 1996. Detection of plasma proteins in CNS: conspicuous influence of tissue-processing parameters and the utilization of serum for blocking non-specific reactions. J Histochem Cytochem 44:591-603.
52. Palmiter RD. 1995. Constitutive expression of metallothionein-III (MT-III), but not MT-I, inhibits growth when cells become zinc deficient. Toxicol Appl Pharmacol 135:139-146.
53. Palmiter RD, Findley SD, Whitmore TE, Durnam DM. 1992. MT-III, a brain specific member of the metallothionein gene family. Proc Natl Acad Sci USA 89:6333-6337.
54. Penkowa M, Hidalgo J, Moos T. 1997. Increased astrocytic expression of metallothioneins I + II in brain stem of adult rats treated with 6-aminonicotinamide. Brain Res 774:256-259.
55. Penkowa M, Moos T. 1995. Disruption of the blood-brain interface in neonatal rat neocortex induces a transient expression of metallothionein in reactive astrocytes. Glia 13:217-227.
56. Perry VH, Bell MD, Brown HC, Matyszak MK. 1995. Inflammation in the nervous system. Curr Opin Neurobiol 5:636-641.
57. Pousset F. 1994. Cytokines as mediators in the central nervous system. Biomed Pharmacother 48:425-431.
58. Ridet JL, Malhotra A, Gage FH. 1997. Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci 20:570-577.
59. Rothwell NJ, Hopkins SJ. 1995. Cytokines and the central nervous system. II. Actions and mechanisms of action. Trends Neurosci 18:130-136.
60. Sato M, Bremner I. 1993. Oxygen free radicals and metallothionein. Free Radical Biol Med 14:325-337.
61. Schroeder JJ, Cousins RJ. 1990. Interleukin 6 regulates metallothionein gene expression and zinc metabolism in hepatocyte monolayer cultures. Proc Natl Acad Sci USA 87:3137-3141.
62. Sewell AK, Jensen LT, Erickson JC, Palmiter RD, Winge DR. 1995. Bioactivity of metallothionein-3 correlates with its novel beta domain sequence rather than metal binding properties. Biochemistry 34:4740-4747.
63. Sillevis Smitt PA, Mulder TP, Verspaget HW, Blaauwgeers HG, Troost D, De Jong JM. 1994. Metallothionein in amyotrophic lateral sclerosis. Biol Signals 3:193-197.
64. Stevens A, Bähr M. 1993. Origin of macrophages in central nervous tissue. J Neurological Sci 118:117-122.
65. Toulmond S, Vige X, Fage D, Benavides J. 1992. Local infusion of interleukin-6 attenuates the neurotoxic effects of NMDA on rat striatal cholinergic neurons. Neurosci Lett 144:49-52.
66. Unsicker K, Grothe C, Westermann R, Wewetzer K. 1992. Cytokines in neural regeneration. Curr Opin Neurobiol 2:671-678.
67. Uchida Y, Takio K, Titani K, Ihara Y, Tomonaga M. 1991. The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein. Neuron 7:337-347.
68. Vela JM, Hidalgo J, González B, Castellano B. 1997. Induction of metallothionein in astrocytes and microglia in the spinal cord from the myelin-deficient jimpy mouse. Brain Res 767:345-355.
69. Yamada M, Hatanaka H. 1994. Interleukin-6 protects cultured rat hippocampal neurons against glutamate-induced cell death. Brain Res 643:173-180.
70. Yuguchi T, Kohmura E, Yamada K, Sakaki T, Yamashita T, Otsuki H, Kataoka K, Tsuji S, Hayakawa T. 1995. Expression of growth inhibitory factor mRNA following cortical injury. J Neurotrauma 12:299-306.